Wednesday, July 06, 2011

Adenoid cystic carcinoma in the news

News about Pfizer funding research on how its drug, Axitinib, affects cancer through the National Comprehensive Cancer Network, including adenoid cystic carcinoma:
http://www.businesswire.com/news/home/20110705005836/en/Researchers-Receive-Grants-NCCN-Oncology-Research-Program 

Sites that were awarded, and type of cancer studied (links to these centers and names of researchers are in the article above):
-Memorial Sloan-Kettering Cancer Center (ACC)
-Roswell Park Cancer Institute (advanced melanoma)
-H. Lee Moffitt Cancer Center & Research Institute (advanced carcinoid tumors)
-University of Michigan Comprehensive Cancer Center (head/neck cancer)

Other studies on this drug in the Clinical Trials database:
http://clinicaltrials.gov/ct2/results?term=axitinib

Research published that mentions the drug name and/or number:
http://www.ncbi.nlm.nih.gov/pubmed?term=axitinib%20OR%20AG013736

Mention of the drug in financial news:
http://search.cnbc.com/main.do?target=all&keywords=axitinib&categories=exclude

The search function on the FDA drug site didn't retrieve anything-but Pfizer has gone for approval, based on its performance on renal cancer:
http://www.fda.gov/Drugs/default.htm

No comments:

 
Who links to my website?